|
1.
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Cancer Treat Res. 152:3–13. 2009. View Article : Google Scholar
|
|
2.
|
Chou AJ and Gorlick R: Chemotherapy
resistance in osteosarcoma: current challenges and future
directions. Expert Rev Anticancer Ther. 6:1075–1085. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Fuchs B and Pritchard DJ: Etiology of
osteosarcoma. Clin Orthop Relat Res. 397:40–52. 2002. View Article : Google Scholar
|
|
4.
|
Akiyama T, Dass CR and Choong PF: Novel
therapeutic strategy for osteosarcoma targeting osteoclast
differentiation, bone-resorbing activity, and apoptosis pathway.
Mol Cancer Ther. 7:3461–3469. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Salvesen GS and Duckett CS: IAP proteins:
blocking the road to death’s door. Nat Rev Mol Cell Biol.
3:401–410. 2002.
|
|
6.
|
Chang H and Schimmer AD: Livin/melanoma
inhibitor of apoptosis protein as a potential therapeutic target
for the treatment of malignancy. Mol Cancer Ther. 6:24–30. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Liston P, Fong WG and Korneluk RG: The
inhibitors of apoptosis: there is more to life than Bcl2. Oncogene.
22:8568–8580. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Nachmias B, Ashhab Y and Ben-Yehuda D: The
inhibitor of apoptosis protein family (IAPs): an emerging
therapeutic target in cancer. Semin Cancer Biol. 14:231–243. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Schimmer AD: Inhibitor of apoptosis
proteins: translating basic knowledge into clinical practice.
Cancer Res. 64:7183–7190. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Gazzaniga P, Gradilone A, Giuliani L, et
al: Expression and prognostic significance of LIVIN, SURVIVIN and
other apoptosis-related genes in the progression of superficial
bladder cancer. Ann Oncol. 14:85–90. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Xi RC, Sheng YR, Chen WH, et al:
Expression of survivin and livin predicts early recurrence in
non-muscle invasive bladder cancer. J Surg Oncol. 107:550–554.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Tanabe H, Yagihashi A, Tsuji N, Shijubo Y,
Abe S and Watanabe N: Expression of survivin mRNA and livin mRNA in
non-small-cell lung cancer. Lung Cancer. 46:299–304. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Xiang Y, Yao H, Wang S, et al: Prognostic
value of Survivin and Livin in nasopharyngeal carcinoma.
Laryngoscope. 116:126–130. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Kempkensteffen C, Hinz S, Christoph F, et
al: Expression of the apoptosis inhibitor livin in renal cell
carcinomas: correlations with pathology and outcome. Tumour Biol.
28:132–138. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Augello C, Caruso L, Maggioni M, et al:
Inhibitors of apoptosis proteins (IAPs) expression and their
prognostic significance in hepatocellular carcinoma. BMC Cancer.
9:1252009. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Dasgupta A, Alvarado CS, Xu Z and Findley
HW: Expression and functional role of inhibitor-of-apoptosis
protein livin (BIRC7) in neuroblastoma. Biochem Biophys Res Commun.
400:53–59. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Xi RC, Biao WS and Gang ZZ: Significant
elevation of survivin and livin expression in human colorectal
cancer: inverse correlation between expression and overall
survival. Onkologie. 34:428–432. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Lazar I, Perlman R, Lotem M, Peretz T,
Ben-Yehuda D and Kadouri L: The clinical effect of the inhibitor of
apopotosis protein livin in melanoma. Oncology. 82:197–204. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Liang YZ, Fang TY, Xu HG and Zhuo ZQ:
Expression of CD44v6 and Livin in gastric cancer tissue. Chin Med J
(Engl). 125:3161–3165. 2012.PubMed/NCBI
|
|
20.
|
Yu L and Wang Z: Effects of Livin gene RNA
interference on apoptosis of cervical cancer HeLa cells and
enhanced sensitivity to cisplatin. J Huazhong Univ Sci Technolog
Med Sci. 29:625–630. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Wang TS, Ding QQ, Guo RH, et al:
Expression of livin in gastric cancer and induction of apoptosis in
SGC-7901 cells by shRNA-mediated silencing of livin gene. Biomed
Pharmacother. 64:333–338. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Yang D, Song X, Zhang J, et al:
Therapeutic potential of siRNA-mediated combined knockdown of the
IAP genes (Livin, XIAP, and Survivin) on human bladder cancer T24
cells. Acta Biochim Biophys Sin (Shanghai). 42:137–144. 2010.
View Article : Google Scholar
|
|
23.
|
Wang X, Xu J, Ju S, Ni H, Zhu J and Wang
H: Livin gene plays a role in drug resistance of colon cancer
cells. Clin Biochem. 43:655–660. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Yang D, Song X, Zhang J, et al:
Suppression of livin gene expression by siRNA leads to growth
inhibition and apoptosis induction in human bladder cancer T24
cells. Biosci Biotechnol Biochem. 74:1039–1044. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Liu H, Wang S, Sun H, Pan Z, Zhou W and Wu
M: Inhibition of tumorigenesis and invasion of hepatocellular
carcinoma by siRNA-mediated silencing of the livin gene. Mol Med
Rep. 3:903–907. 2010.PubMed/NCBI
|
|
26.
|
Yuan B, Ran B, Wang S, Liu Z, Zheng Z and
Chen H: siRNA directed against Livin inhibits tumor growth and
induces apoptosis in human glioma cells. J Neurooncol. 107:81–87.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Chen F, Yang D, Wang S, et al: Livin
regulates prostate cancer cell invasion by impacting the NF-kappaB
signaling pathway and the expression of FN and CXCR4. IUBMB Life.
64:274–283. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Liu X, Wang A, Gao H, Yuan Z and Jiao Y:
Expression and role of the inhibitor of apoptosis protein livin in
chemotherapy sensitivity of ovarian carcinoma. Int J Oncol.
41:1021–1028. 2012.PubMed/NCBI
|
|
29.
|
Nedelcu T, Kubista B, Koller A, et al:
Livin and Bcl-2 expression in high-grade osteosarcoma. J Cancer Res
Clin Oncol. 134:237–244. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Li Y, Li X, Fan G, et al: Impairment of
p53 acetylation by EWS-Fli1 chimeric protein in Ewing family
tumors. Cancer Lett. 320:14–22. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Chen F, Yang D, Che X, et al: Livin
mediates tumor cell invasion in the DU-145 cell line via NF-κB.
Oncol Rep. 27:2010–2016. 2012.PubMed/NCBI
|
|
33.
|
Yuan D, Liu L, Xu H and Gu D: The effects
on cell growth and chemosensitivity by livin RNAi in non-small cell
lung cancer. Mol Cell Biochem. 320:133–140. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Ding ZY, Liu GH, Olsson B and Sun XF:
Upregulation of the antiapoptotic factor Livin contributes to
cisplatin resistance in colon cancer cells. Tumour Biol.
34:683–693. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Wang H, Tan SS, Wang XY, et al: Silencing
livin gene by siRNA leads to apoptosis induction, cell cycle
arrest, and proliferation inhibition in malignant melanoma LiBr
cells. Acta Pharmacol Sin. 28:1968–1974. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Wang R, Lin F, Wang X, et al: Silencing
Livin gene expression to inhibit proliferation and enhance
chemosensitivity in tumor cells. Cancer Gene Ther. 15:402–412.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Ye L, Song X, Li S, et al: Livin-alpha
promotes cell proliferation by regulating G1-S cell cycle
transition in prostate cancer. Prostate. 71:42–51. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Chen YS, Li HR, Miao Y, et al: Local
injection of lentivirus-delivered livinshRNA suppresses lung
adenocarcinoma growth by inducing a G0/G1 phase cell cycle arrest.
Int J Clin Exp Pathol. 5:796–805. 2012.PubMed/NCBI
|
|
39.
|
Bauvois B: New facets of matrix
metalloproteinases MMP-2 and MMP-9 as cell surface transducers:
outside-in signaling and relationship to tumor progression. Biochim
Biophys Acta. 1825:29–36. 2012.PubMed/NCBI
|
|
40.
|
Tabruyn SP and Griffioen AW: A new role
for NF-kappaB in angiogenesis inhibition. Cell Death Differ.
14:1393–1397. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Ma D, Tremblay P, Mahngar K, Collins J,
Hudlicky T and Pandey S: Selective cytotoxicity against human
osteosarcoma cells by a novel synthetic C-1 analogue of
7-deoxypancratistatin is potentiated by curcumin. PLoS One.
6:e287802011. View Article : Google Scholar : PubMed/NCBI
|
